Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
作者信息
Chalmers Z R, Ali S M, Ohgami R S, Campregher P V, Frampton G M, Yelensky R, Elvin J A, Palma N A, Erlich R, Vergilio J-A, Chmielecki J, Ross J S, Stephens P J, Hermann R, Miller V A, Miles C R
机构信息
Foundation Medicine Inc., Cambridge, MA, USA.
Department of Pathology, Stanford School of Medicine, Stanford, CA, USA.
出版信息
Blood Cancer J. 2015 Feb 6;5(2):e278. doi: 10.1038/bcj.2014.95.
Abstract
摘要
Zotero 插件